SCHEMBL21384169

SCHEMBL21384169

COc1cnccc1-c1ccc(Cl)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 1/20 0.41
▸ ATR Q13535 1/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP1A1 P04798 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ CYP11B1 P15538 2/20 0.39
▸ CYP11B2 P19099 2/20 0.39
▸ DYRK1A Q13627 1/20 0.38
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ SLC6A2 P23975 2/20 0.37
▸ SLC6A4 P31645 2/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ CCNT1 O60563 1/20 0.37
▸ CCNA2 P20248 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CDK9 P50750 1/20 0.37
▸ CCNA1 P78396 1/20 0.37
▸ CDK5 Q00535 1/20 0.37
▸ CDK5R1 Q15078 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30592000 1.00 IDH1 (0.41) IDH1ATRCYP1A2CYP1A1CYP1B1
SCHEMBL27718711 0.78 GCGR (0.44) CYP11B1CYP11B2MEN1KMT2ASLC6A2
SCHEMBL12934590 0.76 CYP1A2 (0.49) CYP1A2MEN1KMT2AMETAP2POLB
SCHEMBL31011570 0.76 IDH1 (0.45) IDH1ATRCYP1A2DYRK1ACCNT1
SCHEMBL3600353 0.76 IDH1 (0.45) IDH1ATRCYP1A2DYRK1ACCNT1
SCHEMBL30592070 0.72 TGFBR1 (0.38) CYP1A2CYP1A1CYP1B1MEN1KMT2A
SCHEMBL22946177 0.72 TGFBR1 (0.38) CYP1A2CYP1A1CYP1B1MEN1KMT2A
SCHEMBL18075426 0.71 BTK (0.43) IDH1MEN1KMT2AKDM4EALDH1A1
SCHEMBL30626328 0.70 TLR8 (0.49) CYP1A2MEN1KMT2AKDM4EALDH1A1
SCHEMBL19601141 0.70 TLR8 (0.49) CYP1A2MEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3768667-A1 HETEROCYCLIC COMPOUNDS COMPRISING PYRIDINE USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES Bristol-Myers Squibb Company (US) 2021-01-27 — — EP disclosed
WO-2019183186-A1 HETEROCYCLIC COMPOUNDS COMPRISING PYRIDINE USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES BRISTOL-MYERS SQUIBB COMPANY (US) 2019-09-26 — — WO disclosed
Send feedback